Oxford Biomedica
Pioneering gene and cell therapy with innovative viral vector solutions for pharmaceutical and biotech companies. Learn more
Launch date
Employees
Market cap
€430m
Enterprise valuation
€439m (Public information from Sep 2024)
Share price
£3.51795 OXB.L
Company register number 03252665
Oxford England (HQ)
Authorizing premium user...